Summary & Overview
HCPCS G8530: Autogenous AV Fistula Received
HCPCS Level II code G8530 indicates that a patient has received an autogenous arteriovenous (AV) fistula, a surgically created connection between an artery and a vein using the patient’s own tissue to provide durable vascular access for hemodialysis. Nationally, documentation and coding of AV fistula placement have implications for dialysis quality metrics, vascular access management, and post-operative tracking across payers. This code matters for hospitals and ambulatory surgical centers that manage end-stage renal disease populations and for payers monitoring access-related care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context of autogenous AV fistula placement, expected sites of service, and the role of G8530 in administrative records. The publication provides benchmarks and coding context where available, notes on payer coverage patterns, and pointers to related code groupings and reporting practices. It summarizes the operational and policy relevance of accurate G8530 use for quality measurement, claims processing, and continuity of dialysis care. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code G8530 denotes autogenous arteriovenous (AV) fistula received. This code represents the clinical encounter or service indicating that a patient has received an autogenous AV fistula, a surgically created connection between an artery and a vein using the patient’s own tissue to facilitate vascular access for hemodialysis.
-
Service type: Surgical placement/creation of autogenous vascular access for hemodialysis
-
Typical site of service: Hospital outpatient department or ambulatory surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with end-stage renal disease (ESRD) on hemodialysis is scheduled for placement and maturation monitoring of an autogenous arteriovenous (AV) fistula. The patient presents to an outpatient vascular surgery or interventional nephrology clinic for preoperative evaluation. Relevant history includes long-term dialysis via a tunneled central venous catheter with recurrent catheter-related infections and inadequate flow for dialysis. Preoperative planning includes physical vascular mapping, duplex ultrasound of the upper extremity vessels, and discussion of optimal fistula site (typically radiocephalic or brachiocephalic). The patient is brought to an ambulatory surgery center or hospital outpatient department for creation of the autogenous AV fistula under regional or local anesthesia with sedation. Intraoperative steps include vessel exposure, end-to-side or side-to-side anastomosis of artery to vein, hemostasis, and creation of a venous outflow that will mature over weeks to months. Postoperative workflow includes immediate assessment of thrill/bruit, wound care instructions, scheduled follow-up visits for duplex surveillance, and possible interventions (e.g., angioplasty or banding) if maturation is inadequate. Typical site of service: outpatient surgery center or hospital outpatient department. Typical service type: surgical creation of an autogenous arteriovenous fistula for hemodialysis access (placement of autogenous AV fistula). Typical patient scenario: ESRD patient requiring durable hemodialysis access due to failed or unsuitable central venous catheter or prior graft complications; goal is a native vessel fistula (autogenous) such as radiocephalic or brachiocephalic AV fistula creation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|